Goldberg–Shprintzen syndrome
Goldberg–Shprintzen syndrome (GSS) is a rare genetic disorder characterized by a combination of intestinal abnormalities, distinctive facial features, and neurological issues. It was first described by Goldberg and Shprintzen in the early 1980s.
Clinical Features[edit | edit source]
Individuals with Goldberg–Shprintzen syndrome typically present with a range of clinical features, including:
- Hirschsprung disease: A condition where part of the colon lacks nerve cells, causing severe constipation and intestinal obstruction.
- Microcephaly: A condition where the head is significantly smaller than expected.
- Cleft palate: An opening or split in the roof of the mouth.
- Intellectual disability: Varying degrees of cognitive impairment.
- Distinctive facial features: These may include a broad nasal bridge, wide-set eyes (hypertelorism), and a small jaw (micrognathia).
Genetics[edit | edit source]
Goldberg–Shprintzen syndrome is inherited in an autosomal recessive manner. This means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. The specific gene or genes involved in GSS have not been definitively identified, but research is ongoing to determine the genetic basis of the syndrome.
Diagnosis[edit | edit source]
The diagnosis of Goldberg–Shprintzen syndrome is primarily based on clinical features and family history. Genetic testing may be used to confirm the diagnosis and to identify the specific genetic mutation responsible for the condition.
Management[edit | edit source]
There is no cure for Goldberg–Shprintzen syndrome, and treatment is primarily supportive and symptomatic. Management may include:
- Surgical intervention for Hirschsprung disease.
- Speech therapy for individuals with cleft palate.
- Special education services for those with intellectual disability.
- Regular monitoring and supportive care for other associated health issues.
Related Pages[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
-
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD